302 related articles for article (PubMed ID: 32782084)
21. Prevalence of fentanyl exposure and knowledge regarding the risk of its use among emergency department patients with active opioid use history at an urban medical center in Baltimore, Maryland.
Bach H; Jenkins V; Aledhaim A; Moayedi S; Schenkel SM; Kim HK
Clin Toxicol (Phila); 2020 Jun; 58(6):460-465. PubMed ID: 31475588
[No Abstract] [Full Text] [Related]
22. Association of Opioid and Stimulant Use Disorder Diagnoses With Fatal and Nonfatal Overdose Among People With a History of Incarceration.
Palis H; Gan W; Xavier C; Desai R; Scow M; Sedgemore KO; Greiner L; Nicholls T; Slaunwhite A
JAMA Netw Open; 2022 Nov; 5(11):e2243653. PubMed ID: 36416821
[TBL] [Abstract][Full Text] [Related]
23. The rising threat of illicit amphetamine-type stimulant use among methadone maintenance treatment patients in East Coast Malaysia: a retrospective observational study.
Ismail H; Ahmad H; Sanef A; Shahabudin W; Reffin N; Chan D; Dawam D; Hanan F; Nordin M; Sahar L; Daud K; Bongsu KT; Syezri F; Mustapa H
Am J Drug Alcohol Abuse; 2023 Jan; 49(1):97-108. PubMed ID: 36786756
[No Abstract] [Full Text] [Related]
24. NTP-CERHR monograph on the potential human reproductive and developmental effects of amphetamines.
National Toxicology Program
NTP CERHR MON; 2005 Jul; (16):vii-III1. PubMed ID: 16130031
[TBL] [Abstract][Full Text] [Related]
25. Patient characteristics and treatment utilization in fatal stimulant-involved overdoses in the United States Veterans Health Administration.
Coughlin LN; Zhang L; Bohnert ASB; Maust DT; Goldstick J; Lin LA
Addiction; 2022 Apr; 117(4):998-1008. PubMed ID: 34648209
[TBL] [Abstract][Full Text] [Related]
26. Effectiveness of abstinence-based incentives: interaction with intake stimulant test results.
Stitzer ML; Petry N; Peirce J; Kirby K; Killeen T; Roll J; Hamilton J; Stabile PQ; Sterling R; Brown C; Kolodner K; Li R
J Consult Clin Psychol; 2007 Oct; 75(5):805-11. PubMed ID: 17907862
[TBL] [Abstract][Full Text] [Related]
27. Signals of increasing co-use of stimulants and opioids from online drug forum data.
Sarker A; Al-Garadi MA; Ge Y; Nataraj N; Jones CM; Sumner SA
Harm Reduct J; 2022 May; 19(1):51. PubMed ID: 35614501
[TBL] [Abstract][Full Text] [Related]
28. Anhedonia and amotivation in psychiatric outpatients with fully remitted stimulant use disorder.
Leventhal AM; Kahler CW; Ray LA; Stone K; Young D; Chelminski I; Zimmerman M
Am J Addict; 2008; 17(3):218-23. PubMed ID: 18463999
[TBL] [Abstract][Full Text] [Related]
29. Low concentrations of methamphetamine detectable in urine in the presence of high concentrations of amphetamine.
Jemionek JF; Addison J; Past MR
J Anal Toxicol; 2009 Apr; 33(3):170-3. PubMed ID: 19371467
[TBL] [Abstract][Full Text] [Related]
30. [Identification of Methamphetamine Abuse and Selegiline Use： Chiral Analysis of Methamphetamine and Amphetamine in Urine].
Xiang P; Bu J; Qiao Z; Zhuo XY; Wu HJ; Shen M
Fa Yi Xue Za Zhi; 2017 Dec; 33(6):599-603. PubMed ID: 29441766
[TBL] [Abstract][Full Text] [Related]
31. Cardiac safety of methylphenidate versus amphetamine salts in the treatment of ADHD.
Winterstein AG; Gerhard T; Shuster J; Saidi A
Pediatrics; 2009 Jul; 124(1):e75-80. PubMed ID: 19564272
[TBL] [Abstract][Full Text] [Related]
32. Methamphetamine-Associated Heart Failure Hospitalizations Across the United States: Geographic and Social Disparities.
Dickson SD; Thomas IC; Bhatia HS; Nishimura M; Mahmud E; Tu XM; Lin T; Adler E; Greenberg B; Alshawabkeh L
J Am Heart Assoc; 2021 Aug; 10(16):e018370. PubMed ID: 34365802
[TBL] [Abstract][Full Text] [Related]
33. Opioid, cocaine, and amphetamine use disorders are associated with higher30-day inpatient readmission rates in the United States.
Mejia de Grubb MC; Salemi JL; Gonzalez SJ; Chima CC; Kowalchuk AA; Zoorob RJ
Subst Abus; 2020; 41(3):365-374. PubMed ID: 31295052
[No Abstract] [Full Text] [Related]
34. Stimulant storm - state health department psychostimulant age-adjusted mortality rate correlates with psychostimulant-based Michigan Poison Center case exposures over time.
Vohra V; King A; Daviskiba S; Reed B; Rockhill S; Kern P; Dean D
Clin Toxicol (Phila); 2021 Aug; 59(8):740-745. PubMed ID: 33295798
[TBL] [Abstract][Full Text] [Related]
35. Methamphetamine use in trauma patients: a population-based study.
Schermer CR; Wisner DH
J Am Coll Surg; 1999 Nov; 189(5):442-9. PubMed ID: 10549732
[TBL] [Abstract][Full Text] [Related]
36. Drug-induced bilateral ischemic infarction in an amphetamine addict.
Christensen MR; Lesnikova I; Madsen LB; Rosendal I; Banner J
Forensic Sci Med Pathol; 2013 Sep; 9(3):458-61. PubMed ID: 23504704
[No Abstract] [Full Text] [Related]
37. Beyond methamphetamine: Documenting the implementation of the Matrix model of substance use treatment for opioid users in a South African setting.
Magidson JF; Gouse H; Burnhams W; Wu CY; Myers B; Joska JA; Carrico AW
Addict Behav; 2017 Mar; 66():132-137. PubMed ID: 27940387
[TBL] [Abstract][Full Text] [Related]
38. The methamphetamine epidemic and dentistry.
Klasser GD; Epstein JB
Gen Dent; 2006; 54(6):431-9; quiz 440, 448. PubMed ID: 17134084
[TBL] [Abstract][Full Text] [Related]
39. Association of Medical Stimulants With Mortality in the US From 2010 to 2017.
Black JC; Bau GE; Iwanicki JL; Dart RC
JAMA Intern Med; 2021 May; 181(5):707-709. PubMed ID: 33523100
[TBL] [Abstract][Full Text] [Related]
40. Polymorphisms in CYP2D6 may predict methamphetamine related heart failure.
Sutter ME; Gaedigk A; Albertson TE; Southard J; Owen KP; Mills LD; Diercks DB
Clin Toxicol (Phila); 2013 Aug; 51(7):540-4. PubMed ID: 23855716
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
